Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2005 1
2010 2
2012 2
2013 1
2015 5
2016 3
2017 4
2019 6
2020 4
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Cristino L, Bisogno T, Di Marzo V. Cristino L, et al. Nat Rev Neurol. 2020 Jan;16(1):9-29. doi: 10.1038/s41582-019-0284-z. Epub 2019 Dec 12. Nat Rev Neurol. 2020. PMID: 31831863 Review.
Anecdotal evidence that cannabis preparations have medical benefits together with the discovery of the psychotropic plant cannabinoid delta(9)-tetrahydrocannabinol (THC) initiated efforts to develop cannabinoid-based therapeutics. ...In this Review, we provide an overview …
Anecdotal evidence that cannabis preparations have medical benefits together with the discovery of the psychotropic plant cannabinoid …
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, Frye R. Deepmala, et al. Neurosci Biobehav Rev. 2015 Aug;55:294-321. doi: 10.1016/j.neubiorev.2015.04.015. Epub 2015 May 6. Neurosci Biobehav Rev. 2015. PMID: 25957927 Free article. Review.
In this systematic review we find favorable evidence for the use of NAC in several psychiatric and neurological disorders, particularly autism, Alzheimer's disease, cocaine and cannabis addiction, bipolar disorder, depression, trichotillomania, nail biting, skin pic …
In this systematic review we find favorable evidence for the use of NAC in several psychiatric and neurological disorders, particularly auti …
Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.
Inglet S, Winter B, Yost SE, Entringer S, Lian A, Biksacky M, Pitt RD, Mortensen W. Inglet S, et al. Ann Pharmacother. 2020 Nov;54(11):1109-1143. doi: 10.1177/1060028020930189. Epub 2020 Jun 2. Ann Pharmacother. 2020. PMID: 32483988 Review.
DATA SYNTHESIS: Evidence was compiled and summarized for the following medical conditions: Alzheimer disease, amyotrophic lateral sclerosis, autism, cancer and cancer-associated adverse effects, seizure disorders, human immunodeficiency virus, inflammatory bowel dis …
DATA SYNTHESIS: Evidence was compiled and summarized for the following medical conditions: Alzheimer disease, amyotrophic lateral
Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.
Suryadevara U, Bruijnzeel DM, Nuthi M, Jagnarine DA, Tandon R, Bruijnzeel AW. Suryadevara U, et al. Curr Neuropharmacol. 2017;15(6):800-814. doi: 10.2174/1570159X14666161101095325. Curr Neuropharmacol. 2017. PMID: 27804883 Free PMC article. Review.
These concerns are at least partly due to the strong increase in recreational and medical cannabis use and the rise in tetrahydrocannabinol (THC) levels. Cannabis is widely used to self-medicate by older people and people with brain disorders such as amyotrophic
These concerns are at least partly due to the strong increase in recreational and medical cannabis use and the rise in tetrahydrocann …
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders.
Lim K, See YM, Lee J. Lim K, et al. Clin Psychopharmacol Neurosci. 2017 Nov 30;15(4):301-312. doi: 10.9758/cpn.2017.15.4.301. Clin Psychopharmacol Neurosci. 2017. PMID: 29073741 Free PMC article. Review.
A total of 24 reports that evaluated the use of medical cannabis for Alzheimer's disease, anorexia nervosa, anxiety, dementia, dystonia, Huntington's disease, Parkinson's disease, post-traumatic stress disorder (PTSD), psychosis and Tourette syndrome w …
A total of 24 reports that evaluated the use of medical cannabis for Alzheimer's disease, anorexia nervosa, anxiety, dementia, …
Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial.
Urbi B, Broadley S, Bedlack R, Russo E, Sabet A. Urbi B, et al. BMJ Open. 2019 Nov 11;9(11):e029449. doi: 10.1136/bmjopen-2019-029449. BMJ Open. 2019. PMID: 31719072 Free PMC article.
INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure and with an average life expectancy of 3-5 years post diagnosis. ...However, a clinical trial in pALS with these objectives has not been conducted. METHODS AND ANALY …
INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure and with an average life …
Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials.
Carter GT, Abood ME, Aggarwal SK, Weiss MD. Carter GT, et al. Am J Hosp Palliat Care. 2010 Aug;27(5):347-56. doi: 10.1177/1049909110369531. Epub 2010 May 3. Am J Hosp Palliat Care. 2010. PMID: 20439484
Significant advances have increased our understanding of the molecular mechanisms of amyotrophic lateral sclerosis (ALS), yet this has not translated into any greatly effective therapies. ...With respect to the treatment of ALS, from both a disease modifying and sym …
Significant advances have increased our understanding of the molecular mechanisms of amyotrophic lateral sclerosis (ALS), yet …
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
Pryce G, Baker D. Pryce G, et al. Handb Exp Pharmacol. 2015;231:213-31. doi: 10.1007/978-3-319-20825-1_7. Handb Exp Pharmacol. 2015. PMID: 26408162 Review.
There are numerous reports that people with multiple sclerosis (MS) have for many years been self-medicating with illegal street cannabis or more recently medicinal cannabis to alleviate the symptoms associated with MS and also amyotrophic lateral scle …
There are numerous reports that people with multiple sclerosis (MS) have for many years been self-medicating with illegal street cannabis
Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.
Bedlack RS, Joyce N, Carter GT, Paganoni S, Karam C. Bedlack RS, et al. Neurol Clin. 2015 Nov;33(4):909-36. doi: 10.1016/j.ncl.2015.07.008. Epub 2015 Sep 8. Neurol Clin. 2015. PMID: 26515629 Free PMC article. Review.
Given the severity of their illness and lack of effective disease-modifying agents, it is not surprising that most patients with amyotrophic lateral sclerosis (ALS) consider trying complementary and alternative therapies. Some of the most commonly considered alterna …
Given the severity of their illness and lack of effective disease-modifying agents, it is not surprising that most patients with amyotrop
Survey of cannabis use in patients with amyotrophic lateral sclerosis.
Amtmann D, Weydt P, Johnson KL, Jensen MP, Carter GT. Amtmann D, et al. Am J Hosp Palliat Care. 2004 Mar-Apr;21(2):95-104. doi: 10.1177/104990910402100206. Am J Hosp Palliat Care. 2004. PMID: 15055508
Cannabis (marijuana) has been proposed as treatment for a widening spectrum of medical conditions and has many properties that may be applicable to the management of amyotrophic lateral sclerosis (ALS). This study is the first, anonymous survey of persons wit
Cannabis (marijuana) has been proposed as treatment for a widening spectrum of medical conditions and has many properties that may be
32 results